Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

John M. Buergler, M.D.

John M. Buergler, M.D.

 

John M. Buergler, M.D.

John M. Buergler, M.D.

Assistant Member
The Methodist Hospital Research Institute

Physician, Methodist DeBakey Heart and Vascular Center
Assistant Professor of Medicine 
Weill Cornell Medical College of Cornell University

Phone: 713-441-1100
Fax: 713-790-2643


Education

B.A.   Northwestern University, Chicago, Ill
M.D.   University of Chicago Pritzker School of Medicine, Chicago, Ill

Postdoctoral Training

Internal Medicine Residency, Washington University School of Medicine, St. Louis, MO
Cardiology Fellowship, Baylor College of Medicine, Houston, TX

 

Biography

Dr. Buergler joined the Section of Cardiology in the Department of Medicine at the Baylor College of Medicine in Houston, Texas in 1999 as an Assistant Professor of Medicine, a position held until 2005 when he joined The Methodist Hospital Physician Organization. As a clinical interventional cardiologist, Dr. Buergler has become an expert in alcohol septal ablation, a therapeutic procedure used to relieve the dynamic outflow track obstruction in patients with hypertrophic obstructive cardiomyopathy.

Description of Research

Dr. Buergler´s research interest is in the development of better techniques for improving the results of alcohol septal ablation, including the use of magnetic-guided stereotaxis catheterization.

Major Areas of Research

Hypertrophic obstructive cardiomyopathy, alcohol septal ablation, stereotaxis

Recent Publications

Soon CY, Buergler JM. Alcohol septal ablation and the Brockenbrough-Braunwald phenomenon. Catheter Cardiovasc Interv. 2008 Dec 1;72(7):1016-24. No abstract available.

Buergler JM, Alam S, Spencer W, Kleiman NS, Melendez Y, Franklin J, Nagueh SF. Initial experience with alcohol septal ablation using a novel magnetic navigation system. J Interv Cardiol. 2007 Dec;20(6):559-63.

Nagueh SF, Buergler JM, Quinones MA, Spencer WH 3rd, Lawrie GM. Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007 Aug 21;50(8):795-8. Epub 2007 Aug 6.

Nambi V, Buergler JM, Lakkis NM, Franklin J, Spencer WH 3rd, Nagueh SF. Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease. Am J Cardiol. 2005 Aug 15;96(4):580-1.

Buergler JM, Maliszewski CR, Broekman MJ, Kaluza GL, Schulz DG, Marcus AJ, Raizner AE, Kleiman NS, Ali NM. Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model. J Thromb Thrombolysis. 2005 Apr;19(2):115-22.